Kintsugi 440mg Injection

Kintsugi 440mg Injection

Kintsugi 440mg Injection is a prescription anticancer medicine from Mankind Pharma. Each vial contains 440mg of Trastuzumab as a powder that is mixed before it is given. It is used to treat breast cancer and stomach cancer in which the tumour cells carry too much of a protein called HER2. Trastuzumab is a monoclonal antibody, which is a lab made protein that targets one specific site. It attaches to the HER2 receptor on cancer cells and blocks the growth signals sent through it. It also marks these cells so that the body’s immune system can find and destroy them. The medicine may be given alone or together with chemotherapy, depending on the treatment plan. It is given as a slow infusion into a vein, usually once every week or once every three weeks. Treatment must only take place in a hospital or clinic under a cancer specialist. Heart function is checked before and during therapy because the medicine can affect the heart.

Key Benefits

• Treats HER2 positive early and metastatic breast cancer
• Used for HER2 positive advanced stomach cancer
• Targets cancer cells and spares most healthy cells

Key Features

• Trastuzumab 440mg per vial
• Lyophilised powder for intravenous infusion
• Made by Mankind Pharma

How to Use

• Given only as an IV infusion in a hospital or clinic
• Dose is based on body weight and set by the oncologist
• Store in a refrigerator at 2°C to 8°C and do not freeze

Legal Disclaimer

This information is for general awareness only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified doctor before starting, changing or stopping any medicine. Do not self-medicate. Prescription medicines are supplied only against a valid prescription. PMC Herbals is not responsible for any outcome arising from use of this information. Individual results may vary.